Abstract:Objective To study the expressions of Nodal in normal gallbladder,and gallbladders with cholelithiasis,cholecystitis and carcinoma;and to study the impact of inhibiting or promoting Nodal expressions in gallbladder carcinoma on the Smad2/4 pathway and epithelial-mesenchymal transition.Methods Immunohistochemistry was used to detect the expressions and distributions of Nodal protein in 30 normal gallbladders,96 simple cholecystitis/calculous cholecystitis specimens and 42 gallbladder carcinoma specimens.The mRNA and protein expressions of Nodal in normal and malignant gallbladdcr mucosal epithelium cells and breast cancer cells were detected by RT-PCR,western blotting and wound healing tests.The impact of activating agents and inhibitors on the expression levels of Nodal and its signaling pathway Smad2/4 and EMT-related proteins were analyzed.Results Immunohistochemistry showed that the positive rates of Nodal in the gallbladder cancer group was significantly higher than that in the gallbladder stone group and the normal gallbladder group.The results were 83.3％ (35/42),44.8％ (43/96),6.7％ (2/30) respectively (P＜ 0.01).RT-PCR and Western blotting showed the expressions of Nodal in gallbladder carcinoma cells were higher than normal gallbladder cells (P＜0.05).After using rhNodal to up regulate the Nodal expression,the Smad2 protein phosphorylation was promoted and the EMT associated proteins were up-regulated.After using the inhibitor SB431542 to suppress the Nodal expression,the Smad2 protein phosphorylation decreased and the EMT associated proteins were down-regulated.Conclusions The expression of Nodal was closely related to cell proliferation and metastasis in gallbladder carcinoma.Tumor progression was promoted via the smad2/4 pathway through epithelial-mesenchymal transition.

Nodal Promotes the Generation of M2-Like Macrophages and Downregulates the Expression of Il-12

Endogenous Nodal Promotes Melanoma Undergoing Epithelial-Mesenchymal Transition Via Snail and Slug in Vitro and in Vivo.

Nodal promotes aggressive phenotype via Snail-mediated epithelial-mesenchymal transition in murine melanoma.

Nodal Induces Epithelial-Mesenchymal Transition and Promotes Migration and Invassion of B16 Murine Melanoma Cells

Nodal Promotes Glioblastoma Cell Growth

Nodal Signaling Modulates the Expression of Oct-4 Via Nuclear Translocation of Β-Catenin in Lung and Prostate Cancer Cells

Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway.

Increasing Embryonic Morphogen Nodal Expression Suggests Malignant Transformation in Colorectal Lesions and As a Potential Marker for CMS4 Subtype of Colorectal Cancer

Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance

Nodal Mitigates Cerebral Ischemia-Reperfusion Injury Via Inhibiting Oxidative Stress and Inflammation.

Nodal Promotes the Self-Renewal of Human Colon Cancer Stem Cells Via an Autocrine Manner Through Smad2/3 Signaling Pathway.

Nodal negatively regulates osteoclast differentiation by inducing STAT1 phosphorylation

Nodal Induces Epithelial-Mesenchymal Transition in Gallbladder Carcinoma Via the Smad2/4 Pathway

Nodal Enhances Perineural Invasion in Pancreatic Cancer by Promoting Tumor-Nerve Convergence.

Expression of Nodal on Bronchial Epithelial Cells Influenced by Lung Microbes Through DNA Methylation Modulates the Differentiation of T-Helper Cells.

Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.

Nodal Signaling Activates the Smad2/3 Pathway to Regulate Stem Cell-Like Properties in Breast Cancer Cells.

Nodal Induces Apoptosis Through Activation of the ALK7 Signaling Pathway in Pancreatic INS-1 Β-Cells

TGF-β Promotes Glioma Cell Growth Via Activating Nodal Expression Through Smad and ERK1/2 Pathways

Mir-182 Targeting Reprograms Tumor-Associated Macrophages and Limits Breast Cancer Progression

Nodal Induces Apoptosis Through the Activation of ALK7 Signaling Pathway in Pancreatic Β-Cells